• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用基于网络的生物信息学方法鉴定肝细胞癌的生物标志物。

Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods.

机构信息

Department of Radiology, College of Basic Medicine, Chongqing Medical University, No,1 Yixueyuan Road, Yuzhong District, Chongqing 400016, P,R, China.

出版信息

Eur J Med Res. 2013 Oct 1;18(1):35. doi: 10.1186/2047-783X-18-35.

DOI:10.1186/2047-783X-18-35
PMID:24083576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4016278/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is one of the most common types of cancer worldwide. Despite several efforts to elucidate molecular mechanisms involved in this cancer, they are still not fully understood.

METHODS

To acquire further insights into the molecular mechanisms of HCC, and to identify biomarkers for early diagnosis of HCC, we downloaded the gene expression profile on HCC with non-cancerous liver controls from the Gene Expression Omnibus (GEO) and analyzed these data using a combined bioinformatics approach.

RESULTS

The dysregulated pathways and protein-protein interaction (PPI) network, including hub nodes that distinguished HCCs from non-cancerous liver controls, were identified. In total, 29 phenotype-related differentially expressed genes were included in the PPI network. Hierarchical clustering showed that the gene expression profile of these 29 genes was able to differentiate HCC samples from non-cancerous liver samples. Among these genes, CDC2 (Cell division control protein 2 homolog), MMP2 (matrix metalloproteinase-2) and DCN (Decorin were the hub nodes in the PPI network.

CONCLUSIONS

This study provides a portfolio of targets useful for future investigation. However, experimental studies should be conducted to verify our findings.

摘要

背景

肝细胞癌(HCC)是全球最常见的癌症类型之一。尽管已经做出了一些努力来阐明涉及这种癌症的分子机制,但这些机制仍未被完全理解。

方法

为了更深入地了解 HCC 的分子机制,并确定用于 HCC 早期诊断的生物标志物,我们从基因表达综合数据库(GEO)下载了 HCC 与非癌性肝脏对照的基因表达谱,并使用联合生物信息学方法对这些数据进行了分析。

结果

确定了失调的途径和蛋白质-蛋白质相互作用(PPI)网络,包括区分 HCC 与非癌性肝脏对照的枢纽节点。总共包括 29 个与表型相关的差异表达基因在内的 PPI 网络。层次聚类表明,这些 29 个基因的基因表达谱能够区分 HCC 样本和非癌性肝脏样本。在这些基因中,CDC2(细胞分裂控制蛋白 2 同源物)、MMP2(基质金属蛋白酶-2)和 DCN(Decorin)是 PPI 网络中的枢纽节点。

结论

本研究提供了一组有用的未来研究目标。然而,应进行实验研究来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d481/4016278/ccd17419645c/2047-783X-18-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d481/4016278/435a679dc4e4/2047-783X-18-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d481/4016278/ccd17419645c/2047-783X-18-35-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d481/4016278/435a679dc4e4/2047-783X-18-35-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d481/4016278/ccd17419645c/2047-783X-18-35-2.jpg

相似文献

1
Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods.利用基于网络的生物信息学方法鉴定肝细胞癌的生物标志物。
Eur J Med Res. 2013 Oct 1;18(1):35. doi: 10.1186/2047-783X-18-35.
2
Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.通过生物信息学分析鉴定与肝细胞癌相关的枢纽基因,CYP2C8 是一个有潜力的预后生物标志物。
Gene. 2019 May 25;698:9-18. doi: 10.1016/j.gene.2019.02.062. Epub 2019 Feb 27.
3
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
4
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
5
Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.不同候选基因在 HepG2 细胞或患者肿瘤细胞诱导的肝细胞癌中的生物信息学分析。
J Int Med Res. 2020 Jun;48(6):300060520932112. doi: 10.1177/0300060520932112.
6
Analysis of potential key genes in very early hepatocellular carcinoma.分析极早期肝细胞癌中的潜在关键基因。
World J Surg Oncol. 2019 May 1;17(1):77. doi: 10.1186/s12957-019-1616-6.
7
Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.基于生物信息学分析的肝细胞癌关键生物标志物的筛选和鉴定。
Oncol Rep. 2017 Nov;38(5):2607-2618. doi: 10.3892/or.2017.5946. Epub 2017 Sep 7.
8
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.
9
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析鉴定肝细胞癌的核心基因和预后标志物。
J Cell Biochem. 2019 Jun;120(6):10069-10081. doi: 10.1002/jcb.28290. Epub 2018 Dec 7.
10
Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析的肝细胞癌关键基因和微小RNA的鉴定与相互作用分析
World J Surg Oncol. 2017 Mar 16;15(1):63. doi: 10.1186/s12957-017-1127-2.

引用本文的文献

1
Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.通过转录组学分析探索常见基因组生物标志物,以揭示用于治疗伴有2型糖尿病的结直肠癌和肝细胞癌的常见药物。
PLoS One. 2025 Mar 24;20(3):e0319028. doi: 10.1371/journal.pone.0319028. eCollection 2025.
2
A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma.一种新型四基因特征作为肝细胞癌潜在的预后生物标志物
J Oncol. 2021 Dec 14;2021:1452801. doi: 10.1155/2021/1452801. eCollection 2021.
3
Enrichment and identification of differentially expressed genes in hepatocellular carcinoma stem-like cells.

本文引用的文献

1
Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒 X 蛋白上调 FoxM1 表达促进肿瘤转移,并预示乙型肝炎病毒相关性肝细胞癌的不良预后。
J Hepatol. 2012 Sep;57(3):600-12. doi: 10.1016/j.jhep.2012.04.020. Epub 2012 May 18.
2
Biomarker to distinguish hepatocellular carcinoma from cholangiocarcinoma by serum a disintegrin and metalloprotease 12.血清去整合素金属蛋白酶 12 区分肝细胞癌和胆管细胞癌的生物标志物。
Arch Med Sci. 2011 Dec 31;7(6):1013-6. doi: 10.5114/aoms.2011.26613. Epub 2011 Dec 30.
3
肝癌干细胞样细胞中差异表达基因的富集与鉴定
Oncol Lett. 2020 Dec;20(6):299. doi: 10.3892/ol.2020.12162. Epub 2020 Sep 28.
4
Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.转录组分析确定了肝细胞癌中一种复发性的CRY1-IFT88嵌合转录本。
Oncotarget. 2017 Jun 20;8(25):40693-40704. doi: 10.18632/oncotarget.17244.
5
Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.利用RNA测序对低分化肝细胞癌中差异表达基因进行鉴定及功能分析
Oncotarget. 2017 May 30;8(22):35973-35983. doi: 10.18632/oncotarget.16415.
6
Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.对肝细胞癌患者的匹配肿瘤组织、相邻非肿瘤组织及相应正常血液样本进行全基因组测序,揭示了肝癌发生过程中突变谱的动态变化。
Oncotarget. 2017 Apr 18;8(16):26185-26199. doi: 10.18632/oncotarget.15428.
7
Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma.应用二代测序数据从肝细胞癌的早期和晚期阶段寻找进化网络生物标志物。
Biomed Res Int. 2015;2015:391475. doi: 10.1155/2015/391475. Epub 2015 Aug 20.
8
Derivative component analysis for mass spectral serum proteomic profiles.质谱血清蛋白质组图谱的衍生成分分析。
BMC Med Genomics. 2014;7 Suppl 1(Suppl 1):S5. doi: 10.1186/1755-8794-7-S1-S5. Epub 2014 May 8.
Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.
丙型肝炎病毒感染与肝细胞癌发病率的上升。
Mayo Clin Proc. 2012 Jan;87(1):7-8. doi: 10.1016/j.mayocp.2011.11.004.
4
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
5
Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.细胞角蛋白 19 和基质金属蛋白酶 2 的表达预测肝癌的淋巴结转移。
Mol Biol Rep. 2011 Jun;38(5):3531-9. doi: 10.1007/s11033-010-0463-x. Epub 2010 Nov 23.
6
Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.骨桥蛋白通过上调 MMP-2 和 uPA 的表达促进肝癌侵袭。
Mol Biol Rep. 2011 Aug;38(6):3671-7. doi: 10.1007/s11033-010-0481-8. Epub 2010 Nov 23.
7
Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.鉴定丙型肝炎病毒相关肝细胞癌中优先甲基化的基因。
Cancer Sci. 2010 Jun;101(6):1501-10. doi: 10.1111/j.1349-7006.2010.01549.x. Epub 2010 Feb 27.
8
S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.S100A8和S100A9是小鼠和人类肝癌发生恶性进展过程中的新型核因子κB靶基因。
Hepatology. 2009 Oct;50(4):1251-62. doi: 10.1002/hep.23099.
9
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.利用DAVID生物信息学资源对大型基因列表进行系统和综合分析。
Nat Protoc. 2009;4(1):44-57. doi: 10.1038/nprot.2008.211.
10
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance.TOP2A在肝细胞癌中的过表达与发病年龄早、患者生存期短及化疗耐药相关。
Int J Cancer. 2009 Feb 1;124(3):644-52. doi: 10.1002/ijc.23968.